Surface Ophthalmics, Inc. announced it raised $25.1 Million in an amended filing from an offering of $30.6 Million

Company

Location

About

Surface Ophthalmics is a pioneering biopharmaceutical firm dedicated to the discovery and market introduction of novel treatments for diseases affecting the ocular surface. Our mission is to address critical unmet needs in eye care by harnessing in-depth expertise, a dynamic strategy, operational efficiency, and distinctive clinical advantages.